Navigation Links
PRA Early Phase Experts to Speak at Bioanalysis Conference
Date:11/15/2011

RALEIGH, N.C., Nov. 15, 2011 /PRNewswire/ -- PRA, a leading Clinical Research Organization, announces that two of our Early Development Services (EDS) experts will present at the European Bioanalysis Forum Open Symposium being held in Barcelona, Spain 16-18 November 2011. PRA will also host an exhibit at booth #C3.

On 16 November at 14:45PM CET, Dr. Nico van de Merbel, Scientific Director at PRA's EDS Bioanalytical Laboratory in The Netherlands, will deliver a presentation titled, "Update on Harmonization of Bioanalytical Stability Determination, as part of the Global Bioanalysis Consortium (GBC) Initiative." Dr. van de Merbel's speech will outline his project team's recommendations for new bioanalytical harmonization guidelines.  

On the same day at 17:00PM CET, Dr. Barry W.A. van der Strate, a Senior Project Manager at PRA's EDS Bioanalytical Laboratory in The Netherlands, will present his paper, "Flow Cytometry for Determination of Efficacy in Phase I." Dr. van der Strate will review specific case studies to demonstrate how researchers can use flow cytometry during assay development to investigate compound efficacy for both in vitro and ex vivo trials.

At PRA's exhibit, representatives from our EDS, Business Development and Operations groups will be available to discuss how PRA can support drug development programs.

Dr. van de Merbel, who joined PRA in 1995, is an expert in quantitative bioanalytical chemistry. As PRA's scientific director of small molecule bioanalysis, he is responsible for the development and validation of novel methodologies that support pharmacokinetic and pharmacodynamic analysis in all phases of drug development. In addition, he serves as professor of Industrial Bioanalysis at the University of Groningen.

Dr. van der Strate received a Ph.D. in medical biology from the University of Groningen. He joined PRA in 2008 after completing post-doctorates in pulmonary emphysema and CD34+ cell therapy in neovascularization. As a senior project manager at PRA, Dr. van der Strate specializes in method development and validation of immunochemical assays.

PRA's EDS group conducts Phase I-IIa studies for pharmaceutical and biotechnology clients through our clinics in Europe and the U.S. with bioanalytical laboratories in close proximity to each, facilitating analysis of time-critical patient samples.  Additionally, we operate our Unit on Demand model in Central and Eastern Europe for early phase patient studies.

About PRA

PRA is transforming clinical trials through our people, innovation and transparency.  PRA provides personalized service customized to the unique requirements of each study. We support our global reach and innovative approach through flexible and reliable service, delivered by skilled employees dedicated to ensuring that sponsors achieve their long-term goals.

We serve our clients across all phases of pharmaceutical and biotech drug development by combining therapeutic and operational expertise with local knowledge.  Offering services in 80+ countries and serving sponsors for 30+ years, we have amassed a level of expertise that has enabled us to work on a variety of compounds, ranging from niche treatments and therapies to blockbuster drugs.  But at PRA, we are looking to the future, not the past.  Our increasingly forward-thinking approach to transforming the clinical trial landscape will continue to make a difference to healthcare patients around the world.

To learn more about PRA, please visit praintl.com, email endpoints@praintl.com or call our Global Headquarters.


'/>"/>
SOURCE PRA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk
2. Cerebral Stethoscope Offers New Tool for Early Detection of Aneurysms
3. Augurix Diagnostics Receives the 2011 Debiopharm /Valais Award for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease
4. New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response
5. Fighting Breast Cancer Early, One Cell At A Time
6. Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
7. Covance Receives Good Laboratory Practice Certification for Its Early Development Facility in Shanghai, China
8. DIFICID™ Demonstrated Early Superiority in the First 12 Days Compared to Vancomycin in New Analysis of Phase 3 Study Results
9. President Obama Presents Early Career Award to Dr. Sumita Pennathur
10. Cancer Patients Can Benefit From Early Detection Of Heart Damage Using Echocardiography
11. Phreesias Digital Depression Screening Improves Early Detection and Drives Better Healthcare Outcomes in Medical Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... YORK , May 4, 2016 ... Share, Development, Growth and Demand Forecast to 2022 - Industry ... User (Hospital, Diagnostic Center and Others)" by P&S Market Research, ... $4,894.3 million in 2015, and it is expected to grow ... type, the high slice type segment is expected to witness ...
(Date:5/4/2016)... 4, 2016 In March, ... series of free workshops across Africa ... requirements for Good Distribution Practices (GDP). Good Distribution ... that products are consistently stored, transported and handled under ... or product specification. Only a few years ago, there ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Multiple Myeloma Market ... to their offering.       (Logo: ... Myeloma Market and Competitive Landscape Highlights 2016, ... products, Multiple Myeloma epidemiology, Multiple Myeloma market ...
Breaking Medicine Technology:
(Date:5/4/2016)... , ... May 04, 2016 , ... ... Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy (CAET) will ... time saving and planning tools to attendees and exhibitors for the 2016 WOCN ...
(Date:5/4/2016)... Charles, LA (PRWEB) , ... May 04, 2016 , ... ... Charles, LA area has teamed up with Big Brothers Big Sisters of Southwest Louisiana ... now being accepted here . , Big Brothers Big Sisters of Southwest Louisiana ...
(Date:5/4/2016)... ... May 04, 2016 , ... Washington Wellness Center today announced its tenth anniversary ... What started out as an idea to provide a holistic approach to wellness ... , Developed by Dr. David Swanekamp, Chiropractic Physician , the wellness center offers ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016. SS&A teamed up with one of the top website design companies to ... contains informative legal articles related to the law firm's main practice areas. These ...
(Date:5/4/2016)... ... May 04, 2016 , ... Momsense, ... nursing mothers. The company’s patented technology, The Smart Breastfeeding Meter, is designed to ... that the technology is now available for purchase at Target.com . ...
Breaking Medicine News(10 mins):